264 related articles for article (PubMed ID: 20097933)
1. Risperidone long-acting injection: pharmacokinetics following administration in deltoid versus gluteal muscle in schizophrenic patients.
Thyssen A; Rusch S; Herben V; Quiroz J; Mannaert E
J Clin Pharmacol; 2010 Sep; 50(9):1011-21. PubMed ID: 20097933
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
Li H; Rui Q; Ning X; Xu H; Gu N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
[TBL] [Abstract][Full Text] [Related]
3. A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia.
Cleton A; Rossenu S; Crauwels H; Berwaerts J; Hough D; Gopal S; Eerdekens M; Vandebosch A; Remmerie B; De Meulder M; Rosso CM
J Clin Pharmacol; 2014 Sep; 54(9):1048-57. PubMed ID: 24676998
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia.
Turncliff R; Hard M; Du Y; Risinger R; Ehrich EW
Schizophr Res; 2014 Nov; 159(2-3):404-10. PubMed ID: 25266547
[TBL] [Abstract][Full Text] [Related]
5. [Study on how schizophrenic patients perceive treatment with injections in the deltoid muscle].
Millet B; Gourevitch R; Levoyer D; Parmentier G; Joly C
Encephale; 2012 Feb; 38(1):97-103. PubMed ID: 22381729
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia.
Hough D; Lindenmayer JP; Gopal S; Melkote R; Lim P; Herben V; Yuen E; Eerdekens M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1022-31. PubMed ID: 19481579
[TBL] [Abstract][Full Text] [Related]
7. A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia.
Pandina G; Lane R; Gopal S; Gassmann-Mayer C; Hough D; Remmerie B; Simpson G
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):218-26. PubMed ID: 21092748
[TBL] [Abstract][Full Text] [Related]
8. Inconsistency in risperidone long-acting injection steady-state plasma levels when switching from deltoid to gluteal administration.
Elliott ES; Purvis TL; Nelson LA; Sommi RW
J Clin Pharmacol; 2010 Jun; 50(6):721-4. PubMed ID: 20067943
[No Abstract] [Full Text] [Related]
9. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
11. Patients' acceptance of the deltoid application of risperidone long-acting injection.
Heres S; Frobose T; Hamann J; Leucht S; Maino K; Reichhart T; Stiegler M; Kissling W
Eur Neuropsychopharmacol; 2012 Dec; 22(12):897-901. PubMed ID: 22578781
[TBL] [Abstract][Full Text] [Related]
12. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
[TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia.
Rossenu S; Cleton A; Hough D; Crauwels H; Vandebosch A; Berwaerts J; Eerdekens M; Herben V; De Meulder M; Remmerie B; Francetic I
Clin Pharmacol Drug Dev; 2015 Jul; 4(4):270-8. PubMed ID: 27136907
[TBL] [Abstract][Full Text] [Related]
15. Deltoid injections of risperidone long-acting injectable in patients with schizophrenia.
Quiroz JA; Rusch S; Thyssen A; Palumbo JM; Kushner S
Innov Clin Neurosci; 2011 Jun; 8(6):20-8. PubMed ID: 21779538
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration.
Raoufinia A; Peters-Strickland T; Nylander AG; Baker RA; Eramo A; Jin N; Bricmont P; Repella J; McQuade RD; Hertel P; Larsen F
Int J Neuropsychopharmacol; 2017 Apr; 20(4):295-304. PubMed ID: 28204607
[TBL] [Abstract][Full Text] [Related]
17. A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia.
Anta L; Llaudó J; Ayani I; MartÃnez J; Litman RE; Gutierro I
Int Clin Psychopharmacol; 2018 Mar; 33(2):79-87. PubMed ID: 29112001
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics.
Ereshefsky L; Mascarenas CA
J Clin Psychiatry; 2003; 64 Suppl 16():18-23. PubMed ID: 14680415
[TBL] [Abstract][Full Text] [Related]
19. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
